147 related articles for article (PubMed ID: 8839289)
1. Quantitation of multistage carcinogenesis in rat liver.
Pitot HC; Dragan YP; Teeguarden J; Hsia S; Campbell H
Toxicol Pathol; 1996; 24(1):119-28. PubMed ID: 8839289
[TBL] [Abstract][Full Text] [Related]
2. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat.
Pitot HC; Campbell HA; Maronpot R; Bawa N; Rizvi TA; Xu YH; Sargent L; Dragan Y; Pyron M
Toxicol Pathol; 1989; 17(4 Pt 1):594-611; discussion 611-2. PubMed ID: 2697939
[TBL] [Abstract][Full Text] [Related]
3. The initiation-promotion-progression model of rat hepatocarcinogenesis.
Dragan YP; Sargent L; Xu YD; Xu YH; Pitot HC
Proc Soc Exp Biol Med; 1993 Jan; 202(1):16-24. PubMed ID: 8093813
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
Dragan YP; Hully J; Crow R; Mass M; Pitot HC
Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
[TBL] [Abstract][Full Text] [Related]
5. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers.
Xu YH; Campbell HA; Sattler GL; Hendrich S; Maronpot R; Sato K; Pitot HC
Cancer Res; 1990 Feb; 50(3):472-9. PubMed ID: 1967547
[TBL] [Abstract][Full Text] [Related]
6. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat.
Sargent L; Dragan Y; Xu YH; Sattler G; Wiley J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2985-91. PubMed ID: 8674052
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatocyte phenotypes at the glutathione transferase and albumin loci in Sprague-Dawley and Nagase analbuminemic rats and F1 progeny after initiation and promotion.
Dragan YP; Peterson J; Pitot HC
Carcinogenesis; 1993 Jul; 14(7):1313-9. PubMed ID: 8330343
[TBL] [Abstract][Full Text] [Related]
8. Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
Dragan YP; Singh J; Pitot HC
Carcinogenesis; 1996 Sep; 17(9):2043-52. PubMed ID: 8824533
[TBL] [Abstract][Full Text] [Related]
9. Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats.
Dragan YP; Campbell HA; Baker K; Vaughan J; Mass M; Pitot HC
Carcinogenesis; 1994 Nov; 15(11):2587-91. PubMed ID: 7955110
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of α-lipoic acid on thioacetamide-induced tumor promotion through suppression of inflammatory cell responses in a two-stage hepatocarcinogenesis model in rats.
Fujii Y; Segawa R; Kimura M; Wang L; Ishii Y; Yamamoto R; Morita R; Mitsumori K; Shibutani M
Chem Biol Interact; 2013 Sep; 205(2):108-18. PubMed ID: 23830814
[TBL] [Abstract][Full Text] [Related]
11. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
[TBL] [Abstract][Full Text] [Related]
12. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression.
Dragan Y; Teeguarden J; Campbell H; Hsia S; Pitot H
Cancer Lett; 1995 Jun; 93(1):73-83. PubMed ID: 7600545
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
Steinmetz KL; Klaunig JE
Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
[TBL] [Abstract][Full Text] [Related]
14. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
[TBL] [Abstract][Full Text] [Related]
15. Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis.
Dragan YP; Hully J; Baker K; Crow R; Mass MJ; Pitot HC
Toxicology; 1995 Sep; 102(1-2):161-75. PubMed ID: 7482551
[TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
[TBL] [Abstract][Full Text] [Related]
17. A semipurified diet that suppresses phenobarbital promotion of hepatocarcinogenesis in the rat.
Hendrich S; Glauert HP; Pitot HC
Nutr Cancer; 1989; 12(3):249-58. PubMed ID: 2771802
[TBL] [Abstract][Full Text] [Related]
18. Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model.
Ichimura R; Mizukami S; Takahashi M; Taniai E; Kemmochi S; Mitsumori K; Shibutani M
Toxicol Appl Pharmacol; 2010 Aug; 246(3):128-40. PubMed ID: 20423715
[TBL] [Abstract][Full Text] [Related]
19. Cancer initiating properties of fumonisin B1 in a short-term rat liver carcinogenesis assay.
Gelderblom WC; Marasas WF; Lebepe-Mazur S; Swanevelder S; Abel S
Toxicology; 2008 Sep; 250(2-3):89-95. PubMed ID: 18616970
[TBL] [Abstract][Full Text] [Related]
20. Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat.
Pitot HC; Dragan Y; Sargent L; Xu YH
Environ Health Perspect; 1991 Jun; 93():181-9. PubMed ID: 1723043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
